Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population

Cellular Immunology

Volumn 273, Issue 1, 2012, Pages 67-72

  Mohamed, Rasha H ^a   Pasha, Heba F ^b   El Shahawy, Eman E ^b  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Egyptian population; Polymorphism; Rheumatoid arthritis; STAT; TRAF1 C5

Indexed keywords

STAT4 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; AGED; ALLELE; ARTICLE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EGYPT; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CHI-SQUARE DISTRIBUTION; DNA; EGYPT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATOID FACTOR; STAT4 TRANSCRIPTION FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 84856016201     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.11.005     Document Type: Article

References (37)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis [review]. Nature 2003, 423:356-361.
2. Van A.H., Wesoly J.Z., Huizinga T.W. Understanding the genetic contribution to rheumatoid arthritis. Curr. Opin. Rheumatol. 2005, 17:299-304.
3. Bowes J., Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008, 47:399-402.
4. Kurreeman F.A., Padyukov L., Marques R.B., Schrodi S.J., Seddighzadeh M., Stoeken-Rijsbergen G., Helm-van A.H., Allaart C.F., Verduyn W., Houwing-Duistermaat J., Alfredsson L., Begovich A.B., Klareskog L., Huizinga T.W., Toes R.E. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007, 4:1515-1524.
5. Lee H.S., Remmers E.F., Le J.M., Kastner D.L., Bae S.C., Gregersen P.K. Association of STAT4 with rheumatoid arthritis in the Korean population. Arthritis Rheum. 2008, 58:2598-2602.
6. Weinblatt M.E., Kremer J.M., Bankhurst A.D., Bulpitt K.J., Fleischmann R.M., Fox R.I., Jackson C.G., Lange M., Burge D.J. A trial of Etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 1999, 340:253-259.
7. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 2007, 357:977-986.
8. Lee H.S., Remmers E.F., Le J.M., Kastner D.L., Bae S.C., Gregersen P.K. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol. Med. 2007, 13:455-460.
9. Frucht D.M., Aringer M., Galon J., Danning C., Akrad M., Brown M., Centola M., Wu C.Y., Yamada N., Cheng T., Fan S., Steiner G., El-Gabalawy H., O'Shea J.J. STAT4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 2000, 164:4659-4664.
10. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2002, 2:933-944.
11. Nishikomori R., Usui T., Wu C.Y., Morinobu A., O'Shea J.J., Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J. Immunol. 2002, 169:4388-4398.
12. Cai G., Radzanowski T., Villegas E.N., Kastelein R., Hunter C.A. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J. Immunol. 2000, 165:2619-2627.
13. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., Kapur R., Levy D.E., Kansas G.S., Kaplan M.H. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 2007, 178:4901-4907.
14. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
15. Prevoo M.L., van 't Hof M.A., Kuper H.H., van Leeuwen M.A., vande Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts: development and validationin a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38:44-48.
16. Sharp J.T. An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in misanalysis. J. Rheumatol. 2000, 27:254-260.
17. Zervou M.I., Sidiropoulos P., Petraki E., Vazgiourakis V., Krasoudaki E., Raptopoulou A., Kritikos H., Choustoulaki E., Boumpas D.T., Goulielmos G.N. Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum. Immunol. 2008, 69:567-571.
18. Plant D., Thomson W., Lunt M., Flynn E., Martin P., Eyre S., Farragher T., Bunn D., Worthington J., Symmons D., Barton A. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology 2011, 50:78-84.
19. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., Pe'er I., Burtt N.P., Blumenstiel B., DeFelice M., Parkin M., Barry R., Winslow W., Healy C., Graham R.R., Neale B.M., Izmailova E., Roubenoff R., Parker A.N., Glass R., Karlson E.W., Maher N., Hafler D.A., Lee D.M., Seldin M.F., Remmers E.F., Lee A.T., Padyukov L., Alfredsson L., Coblyn J., Weinblatt M.E., Gabriel S.B., Purcell S., Klareskog L., Gregersen P.K., Shadick N.A., Daly M.J., Altshuler D. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 2007, 39:1477-1482.
20. Sigurdsson S., Padyukov L., Kurreeman F.A., Liljedahl U., Wiman A.C., Alfredsson L., Toes R., Rönnelid J., Klareskog L., Huizinga T.W., Alm G., Syvänen A.C., Rönnblom L. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum. 2007, 56:2202-2210.
21. Van der Helm-van Mil A.H., Huizinga T.W. Advances in the genetics of rheumatoid arthritis point to sub classification into distinct disease subsets. Arthritis Res. Ther. 2008, 10:205.
22. Kurreeman F.A.S., Rocha D., Houwing-Duistermaat J., Vrijmoet S., Teixeira V.H., Migliorini P., Balsa A., Westhovens R., Barrera P., Alves H., Vaz C., Fernandes M., Pascual-Salcedo D., Michou L., Bombardieri S., Radstake T., Van Riel P., van de Putte L., Lopes-Vaz A., Prum B., Bardin T., Gut I., Cornelis F., Huizinga T.W.J., Petit-Teixeira E., Toes R.E.M. Replication of the tumor necrosis factor receptor_associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study. Arthritis Rheum. 2008, 58:2670-2674.
23. Chakravarti D., La-Morte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., Evans R.M. Role of CBP/P300 in nuclear receptor signaling. Nature 1996, 383:99-108.
24. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447:661-678. The Wellcome Trust Case Control Consortium.
25. Van Gaalen F., Ioan-Facsinay A., Huizinga T.W., Toes R.E. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J. Immunol. 2005, 175:5575-5580.
26. Han T.U., Bang S.Y., Kang C., Bae S.C. TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians. Arthritis Rheum. 2009, 175:2577-2584.
27. Panoulas V.F., Smith J.P., Nightingale P., Kitas G.D. Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthritis Rheum. 2009, 60:39-46.
28. Kobayashi S., Ikari K., Kaneko H., Kochi Y., Yamamoto K., Shimane K., Nakamura Y., Toyama Y., Mochizuki T., Tsukahara S., Kawaguchi Y., Terai C., Hara M., Tomatsu T., Yamanaka H., Horiuchi T., Tao K., Yasutomo K., Hamada D., Yasui N., Inoue H., Itakura M., Okamoto H., Kamatani N., Momohara S. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum. 2008, 58:1940-1946.
29. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., González-Gay M.A., Balsa A., Pascual-Salcedo D., Fernández-Gutierrez B., González-Escribano M.F., Petersson I.F., van Riel P.L., Barrera P., Coenen M.J., Radstake T.R., van Leeuwen M.A., Wijmenga C., Koeleman B.P., Alarcón-Riquelme M., Martín J. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum. 2008, 58:1974-1980.
30. Palomino-Morales R.J., Rojas-Villarraga A., Gonzalez C.I., Ramirez G., Anaya J.M., Martin J. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun. 2008, 9:379-382.
31. Kaplan M. STAT4: a critical regulator of inflammation in vivo. Immunol. Res. 2005, 31:231-242.
32. Kariuki S.N., Kirou K.A., MacDermott E.J., Barillas-Arias L., Crow M.K., Niewold T.B. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-α in lupus patients in vivo. J. Immunol. 2009, 182:34-38.
33. Martnez A., Varadé J., Márquez A., Cénit M.C., Espino L., Perdigones N., Santiago J.L., Ferndndez-Arquero M., de la Calle H., Arroyo R., Mendoza J.L., Fernández-Gutiérrez B., de la Concha E.G. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum. 2008, 58:2598-2602.
34. Barton A., Thomson W., Ke X., Eyre S., Hinks A., Bowes J., Gibbons L.J., Plant D., Wilson A., Marinou I., Morgan A., Emery P., Steer S., Hocking L., Reid D., Wordsworth P., Harrison P., Worthington J. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum. Mol. Genet. 2008, 17:2274-2279. Wellcome Trust Case Control Consortium.
35. Ji J.D., Lee W.J., Kong K.A., Woo J.H., Choi S.J., Lee Y.H., Song G.G. Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol. Biol. Rep. 2010, 37:141-147.
36. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Gyu G. Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis. Rheumatol. Int. 2010, 30:661-666.
37. Morgan A.W., Robinson J.I., Conaghan P.G., Martin S.G., Hensor E.A., Morgan M.D., Steiner L., Erlich H.A., Gooi H.C., Barton A., Worthington J., Emery P. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Res. Ther. 2010, 12:57-62.